PRR11 is a prognostic biomarker and correlates with immune infiltrates in bladder urothelial carcinoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
PRR11 is a prognostic biomarker and correlates with immune infiltrates in bladder urothelial carcinoma ; volume:13 ; number:1 ; day:4 ; month:2 ; year:2023 ; pages:1-15 ; date:12.2023
Scientific reports ; 13, Heft 1 (4.2.2023), 1-15, 12.2023
- Creator
-
Ni, Wenpeng
Yi, Lijuan
Dong, Xiaoru
Cao, Mengjie
Zheng, Jinjuan
Wei, Qingling
Yuan, Chunlei
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-29316-2
- URN
-
urn:nbn:de:101:1-2023040909055450489570
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ni, Wenpeng
- Yi, Lijuan
- Dong, Xiaoru
- Cao, Mengjie
- Zheng, Jinjuan
- Wei, Qingling
- Yuan, Chunlei
- SpringerLink (Online service)
Other Objects (12)
TCN1 is a potential prognostic biomarker and correlates with immune infiltrates in lung adenocarcinoma
Overexpressed VDAC1 in breast cancer as a novel prognostic biomarker and correlates with immune infiltrates
Transcriptome sequencing identifies ANLN as a promising prognostic biomarker in bladder urothelial carcinoma
Molecular classification of urothelial bladder carcinoma
ARID1A-deficiency in urothelial bladder cancer: No predictive biomarker for EZH2-inhibitor treatment response?
Ferroptosis-related gene SLC1A5 is a novel prognostic biomarker and correlates with immune infiltrates in stomach adenocarcinoma
Preliminary evaluation of urinary soluble Met as a Biomarker for urothelial carcinoma of the bladder
MTHFD2 is a potential oncogene for its strong association with poor prognosis and high level of immune infiltrates in urothelial carcinomas of bladder
CD10 expression in urothelial carcinoma of the bladder
Promoter hypermethylation of tumor suppressor genes correlates with tumor grade and invasiveness in patients with urothelial bladder cancer
Rectal metastasis from bladder urothelial carcinoma: a case report
Integrated proteogenomic characterization of urothelial carcinoma of the bladder
TCN1 is a potential prognostic biomarker and correlates with immune infiltrates in lung adenocarcinoma
Overexpressed VDAC1 in breast cancer as a novel prognostic biomarker and correlates with immune infiltrates
Transcriptome sequencing identifies ANLN as a promising prognostic biomarker in bladder urothelial carcinoma
Molecular classification of urothelial bladder carcinoma
ARID1A-deficiency in urothelial bladder cancer: No predictive biomarker for EZH2-inhibitor treatment response?
Ferroptosis-related gene SLC1A5 is a novel prognostic biomarker and correlates with immune infiltrates in stomach adenocarcinoma
Preliminary evaluation of urinary soluble Met as a Biomarker for urothelial carcinoma of the bladder
MTHFD2 is a potential oncogene for its strong association with poor prognosis and high level of immune infiltrates in urothelial carcinomas of bladder
CD10 expression in urothelial carcinoma of the bladder
Promoter hypermethylation of tumor suppressor genes correlates with tumor grade and invasiveness in patients with urothelial bladder cancer
Rectal metastasis from bladder urothelial carcinoma: a case report
Integrated proteogenomic characterization of urothelial carcinoma of the bladder
TCN1 is a potential prognostic biomarker and correlates with immune infiltrates in lung adenocarcinoma
Overexpressed VDAC1 in breast cancer as a novel prognostic biomarker and correlates with immune infiltrates
Transcriptome sequencing identifies ANLN as a promising prognostic biomarker in bladder urothelial carcinoma
Molecular classification of urothelial bladder carcinoma
ARID1A-deficiency in urothelial bladder cancer: No predictive biomarker for EZH2-inhibitor treatment response?
Ferroptosis-related gene SLC1A5 is a novel prognostic biomarker and correlates with immune infiltrates in stomach adenocarcinoma
Preliminary evaluation of urinary soluble Met as a Biomarker for urothelial carcinoma of the bladder
MTHFD2 is a potential oncogene for its strong association with poor prognosis and high level of immune infiltrates in urothelial carcinomas of bladder
CD10 expression in urothelial carcinoma of the bladder
Promoter hypermethylation of tumor suppressor genes correlates with tumor grade and invasiveness in patients with urothelial bladder cancer
Rectal metastasis from bladder urothelial carcinoma: a case report